Andere talen Tianjin Lisheng Pharmaceutical Co.,Ltd.

Aandelen

002393

CNE100000NJ9

slotkoers Shenzhen S.E. Andere beurzen 00:00:00 10-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
26,29 ^CNY	-1,90%		+3,30%	+0,73%

24/04	Tianjin Lisheng Pharmaceutical Co.,Ltd. Rapporteert resultaten voor het eerste kwartaal dat eindigde op 31 maart 2024	CI
22/03	Winst Tianjin Lisheng Pharmaceutical's in 2023 stijgt door winst uit verkoop van activa; aandelen stijgen 4%.	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Tianjin Lisheng Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	24/04
Tianjin Lisheng Pharmaceutical Co.,Ltd. Proposes Cash Dividend for the Year 2023	22/03
Tianjin Lisheng Pharmaceutical's 2023 Profit Surges on Gains from Asset Disposals; Shares Jump 4%	22/03
Tianjin Lisheng Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	26/02
Lisheng Pharmaceutical Buys 65% Stake in Qingchun Kangyuan Pharmaceutical for 137 Million Yuan; Shares Up 3%	02/01
Tianjin Arm Lisheng Pharmaceutical To Buy Chinese Medicine Firm Jiangxi Qingchun Kangyuan	14/12
Tianjin Lisheng Pharmaceutical Co.,Ltd. agreed to acquire 65% stake in Jiangxi Qingchun Kangyuan Pharmaceutical Co., Ltd. from Jiangxi Qingchun Kangyuan Group Co., Ltd. and Jiangxi Qingchun Kangyuan Chinese Medicine Co., Ltd. for approximately CNY 140 million.	14/12
Tianjin Lisheng Pharma Setting Up Venture Capital Fund	12/12
Lisheng Pharmaceutical and Lisheng Investment Enter into the Partnership Agreement with Bozheng Capital, Tianjin Jinjia and Tianjin Handeway	11/12
Tianjin Development to Vote Dec. 5 on Lisheng Pharma's Sale of Tianjin Pharmaceutical Finance Stake	10/11
Tianjin Lisheng Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	29-10-23
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited agreed to acquire additional 15% stake in Tianjin Pharmaceutical Group Finance Co., Ltd from Tianjin Lisheng Pharmaceutical Co.,Ltd. for CNY 87.8 million.	11-09-23
Lisheng Pharmaceutical's H1 Attributable Profit Jumps	25-08-23
Tianjin Lisheng Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	24-08-23
Lisheng Pharmaceutical Subscribes for 20 Million Yuan Wealth Management Product	02-08-23
Lisheng Pharma to Receive 247.9 Million Yuan for Relocation	26-07-23
Lisheng Pharmaceutical Eyes 247.9 Million Yuan from Potential Land Resumption Deal	26-07-23
Tianjin Lisheng Pharmaceutical Co.,Ltd. Announces 2022 Final Profit Distribution Plan to Be Implemented (A Shares), Payment Date Is 30 June 2023	20-06-23
Tianjin Lisheng Pharma Gets Nod For Febuxostat Active Pharma Ingredient in China	15-06-23
Lisheng Pharma Unit's Drug Passes Regulatory Evaluation	15-05-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Tianjin Lisheng Pharmaceutical Co.,Ltd.

Aandelen

002393

CNE100000NJ9

Andere talen

Filters